Skip to main content
. 2013 Jul;65(4):388–394. doi: 10.1016/j.ihj.2013.06.026

Table 5.

One-year clinical follow-up.

From admission to 12 month FU (n = 47)
Cardiac death 1 (2.1%)
Myocardial Infarction 0
Reintervention – TLR 2 (4.3%)
Major adverse cardiac events (defined as: death, myocardial infarction, TLR) 6.4% (3 – one cardiac death, two TLR)
Stent thrombosis (ARC)
 Definite 0 (0%)
 Probable 0 (0%)
 Possible 1 (2.1%)